Menu
GWAS Study

GWAS of stool frequency provides insights into gastrointestinal motility and irritable bowel syndrome.

Bonfiglio F, Liu X, Smillie C et al.

34957435 PubMed ID
GWAS Study Type
167875 Participants
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

BF
Bonfiglio F
LX
Liu X
SC
Smillie C
PA
Pandit A
KA
Kurilshikov A
BR
Bacigalupe R
ZT
Zheng T
NH
Nim H
GK
Garcia-Etxebarria K
BL
Bujanda L
AA
Andreasson A
AL
Agreus L
WS
Walter S
AG
Abecasis G
EC
Eijsbouts C
JL
Jostins L
PM
Parkes M
HD
Hughes DA
TN
Timpson N
RJ
Raes J
FA
Franke A
KN
Kennedy NA
RA
Regev A
ZA
Zhernakova A
SM
Simren M
CM
Camilleri M
DM
D'Amato M
Chapter II

Abstract

Summary of the research findings

Gut dysmotility is associated with constipation, diarrhea, and functional gastrointestinal disorders like irritable bowel syndrome (IBS), although its molecular underpinnings are poorly characterized. We studied stool frequency (defined by the number of bowel movements per day, based on questionnaire data) as a proxy for gut motility in a GWAS meta-analysis including 167,875 individuals from UK Biobank and four smaller population-based cohorts. We identify 14 loci associated with stool frequency (p ≤ 5.0 × 10-8). Gene set and pathway analyses detected enrichment for genes involved in neurotransmitter/neuropeptide signaling and preferentially expressed in enteric motor neurons controlling peristalsis. PheWAS identified pleiotropic associations with dysmotility syndromes and the response to their pharmacological treatment. The genetic architecture of stool frequency correlates with that of IBS, and UK Biobank participants from the top 1% of stool frequency polygenic score distribution were associated with 5× higher risk of IBS with diarrhea. These findings pave the way for the identification of actionable pathological mechanisms in IBS and the dysmotility syndromes.

167,875 European ancestry individuals

Chapter III

Study Statistics

Key metrics and study information

167875
Total Participants
GWAS
Study Type
No
Replicated
European
Ancestry
Belgium, Netherlands, Sweden, U.K., U.S.
Recruitment Country
Chapter IV

Analysis

Comprehensive review of health and genetic findings

Important Disclaimer: This review has been performed semi-automatically and is provided for informational purposes only. While we strive for accuracy, this analysis may contain errors, omissions, or misinterpretations of the original research. DNA Genics disclaims all liability for any inaccuracies, errors, or consequences arising from the use of this information. Users should independently verify all information and consult original research publications before making any decisions based on this content. This analysis is not intended as a substitute for professional scientific review or medical advice.

Analysis In Progress

Our analysis of this publication is currently being prepared. Please check back soon for comprehensive insights into the health and genetic findings discussed in this research.